Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pieter C Smits

Showing results (141-150 of 186) with videos related to

Pageof 19
Sort By:
Journal of Clinical Medicine|October 28, 2023
Direct Stenting versus Conventional Stenting in Patients with ST-Segment Elevation Myocardial Infarction-A COMPARE CRUSH Sub-StudyRosanne F Vogel, Ronak Delewi, Jeroen M Wilschut, et al.
JACC. Cardiovascular Interventions|June 25, 2021
Pharmacodynamic Effects of Pre-Hospital Administered Crushed Prasugrel in Patients With ST-Segment Elevation Myocardial InfarctionRosanne F Vogel, Ronak Delewi, Dominick J Angiolillo, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes MellitusAlexander Thomas, Dean J Kereiakes, Andreas Baumbach, et al.
American Heart Journal|June 7, 2022
Pre-hospital treatment with crushed versus integral tablets of prasugrel in patients presenting with ST-Segment Elevation Myocardial Infarction-1-year follow-up results of the COMPARE CRUSH trialRosanne F Vogel, Ronak Delewi, Jeroen M Wilschut, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 2, 2024
Prehospital crushed versus integral prasugrel loading dose in STEMI patients with a large myocardial areaJeroen M Wilschut, Rosanne F Vogel, Jacob J Elscot, et al.
European Heart Journal|January 1, 2019
Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient dataFrederik M Zimmermann, Elmir Omerovic, Stephane Fournier, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 17, 2025
Impact of elevated lipoprotein(a) on epicardial coronary flow conductance and endoluminal atherosclerotic disease distributionMick P L Renkens, Tsung-Ying Tsai, Pruthvi C Revaiah, et al.
American Heart Journal|January 3, 2023
Sex-stratified differences in early antithrombotic treatment response in patients presenting with ST-segment elevation myocardial infarctionRonak Delewi, Rosanne F Vogel, Jeroen M Wilschut, et al.
JACC. Cardiovascular Interventions|April 12, 2023
Abbreviated or Standard Antiplatelet Therapy in HBR Patients: Final 15-Month Results of the MASTER-DAPT TrialAntonio Landi, Dik Heg, Enrico Frigoli, et al.
Circulation. Cardiovascular Interventions|July 13, 2026
Abbreviated Dual Antiplatelet Therapy in Patients With High Bleeding Risk Undergoing PCI of Bifurcation Lesions: A Prespecified Substudy of the MASTER DAPT TrialBernard Chevalier, Davide Cao, Pieter C Smits, et al.
Pageof 19

Showing results (141-150 of 186) with videos related to

Sort By:
Pageof 19
Journal of Clinical Medicine|October 28, 2023
Direct Stenting versus Conventional Stenting in Patients with ST-Segment Elevation Myocardial Infarction-A COMPARE CRUSH Sub-StudyRosanne F Vogel, Ronak Delewi, Jeroen M Wilschut, et al.
JACC. Cardiovascular Interventions|June 25, 2021
Pharmacodynamic Effects of Pre-Hospital Administered Crushed Prasugrel in Patients With ST-Segment Elevation Myocardial InfarctionRosanne F Vogel, Ronak Delewi, Dominick J Angiolillo, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes MellitusAlexander Thomas, Dean J Kereiakes, Andreas Baumbach, et al.
American Heart Journal|June 7, 2022
Pre-hospital treatment with crushed versus integral tablets of prasugrel in patients presenting with ST-Segment Elevation Myocardial Infarction-1-year follow-up results of the COMPARE CRUSH trialRosanne F Vogel, Ronak Delewi, Jeroen M Wilschut, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 2, 2024
Prehospital crushed versus integral prasugrel loading dose in STEMI patients with a large myocardial areaJeroen M Wilschut, Rosanne F Vogel, Jacob J Elscot, et al.
European Heart Journal|January 1, 2019
Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient dataFrederik M Zimmermann, Elmir Omerovic, Stephane Fournier, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 17, 2025
Impact of elevated lipoprotein(a) on epicardial coronary flow conductance and endoluminal atherosclerotic disease distributionMick P L Renkens, Tsung-Ying Tsai, Pruthvi C Revaiah, et al.
American Heart Journal|January 3, 2023
Sex-stratified differences in early antithrombotic treatment response in patients presenting with ST-segment elevation myocardial infarctionRonak Delewi, Rosanne F Vogel, Jeroen M Wilschut, et al.
JACC. Cardiovascular Interventions|April 12, 2023
Abbreviated or Standard Antiplatelet Therapy in HBR Patients: Final 15-Month Results of the MASTER-DAPT TrialAntonio Landi, Dik Heg, Enrico Frigoli, et al.
Circulation. Cardiovascular Interventions|July 13, 2026
Abbreviated Dual Antiplatelet Therapy in Patients With High Bleeding Risk Undergoing PCI of Bifurcation Lesions: A Prespecified Substudy of the MASTER DAPT TrialBernard Chevalier, Davide Cao, Pieter C Smits, et al.
Pageof 19